BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$799M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$470M |
| 3 |
Alibaba
BABA
|
+$222M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$113M |
| 5 |
Ambev
ABEV
|
+$97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.34B |
| 2 |
Apple
AAPL
|
+$308M |
| 3 |
Bank of America
BAC
|
+$261M |
| 4 |
Microsoft
MSFT
|
+$251M |
| 5 |
Amazon
AMZN
|
+$231M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.65% |
| 2 | Technology | 11.07% |
| 3 | Healthcare | 9.66% |
| 4 | Communication Services | 9.34% |
| 5 | Consumer Discretionary | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OME
3076
DELISTED
Omega Protein
OME
| $56.6K | ﹤0.01% |
3,160
+842
| +36% | +$15.7K |
|
3077
Midland States Bancorp
MSBI
$698M
| $56.5K | ﹤0.01% |
1,686
+1,653
| +5,009% | +$56.5K |
|
|
HTB
3078
HomeTrust Bancshares
HTB
$837M
| $56.4K | ﹤0.01% |
2,312
+2,106
| +1,022% | +$51.8K |
|
3079
Regenxbio
RGNX
$704M
| $56.3K | ﹤0.01% |
2,853
+2,023
| +244% | +$39.2K |
|
|
EGC
3080
DELISTED
Energy XXI Gulf Coast, Inc. Common Stock
EGC
| $56.3K | ﹤0.01% |
+3,032
| New | +$78K |
|
3081
Aclaris Therapeutics
ACRS
$863M
| $55.9K | ﹤0.01% |
2,062
+2,037
| +8,148% | +$55.4K |
|
|
UN
3082
DELISTED
Unilever NV New York Registry Shares
UN
| $55.8K | ﹤0.01% |
1,009
| – | – |
|
|
ASCMA
3083
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
| $55.6K | ﹤0.01% |
3,619
+1,089
| +43% | +$15.1K |
|
3084
Acushnet Holdings
GOLF
$5.25B
| $55.2K | ﹤0.01% |
2,781
+2,410
| +650% | +$45.1K |
|
3085
Harmony Gold Mining
HMY
$12B
| $55.2K | ﹤0.01% |
33,429
-74,715
| -69% | -$160K |
|
|
LJPC
3086
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $55.1K | ﹤0.01% |
1,852
+1,784
| +2,624% | +$51.1K |
|
|
ITCI
3087
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $55.1K | ﹤0.01% |
4,439
+3,683
| +487% | +$42.7K |
|
|
REV
3088
DELISTED
Revlon, Inc.
REV
| $55.1K | ﹤0.01% |
2,323
+1,661
| +251% | +$37.7K |
|
|
ROCC
3089
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $54.9K | ﹤0.01% |
+1,495
| New | +$63.4K |
|
|
HTBK
3090
DELISTED
Heritage Commerce
HTBK
| $54.9K | ﹤0.01% |
3,983
+3,806
| +2,150% | +$52.7K |
|
3091
Alpha and Omega Semiconductor
AOSL
$916M
| $54.9K | ﹤0.01% |
3,291
+1,586
| +93% | +$28.2K |
|
|
PDLI
3092
DELISTED
PDL BioPharma, Inc.
PDLI
| $54.8K | ﹤0.01% |
22,166
+18,478
| +501% | +$42.5K |
|
|
TBHC
3093
DELISTED
The Brand House Collective
TBHC
| $54.6K | ﹤0.01% |
5,315
+2,334
| +78% | +$24.9K |
|
3094
PUT
Chubb
CB
$133B
| $54.1K | ﹤0.01% |
865
+23
| +3% | +$3.24K |
|
3095
Nicolet Bankshares
NIC
$3.73B
| $54.1K | ﹤0.01% |
989
+931
| +1,605% | +$46.8K |
|
3096
UBS Group
UBS
$176B
| $54.1K | ﹤0.01% |
3,186
-9,162
| -74% | -$149K |
|
3097
TG Therapeutics
TGTX
$7.34B
| $54.1K | ﹤0.01% |
5,381
+5,066
| +1,608% | +$56.7K |
|
|
ACTA
3098
DELISTED
Actua Corp
ACTA
| $54.1K | ﹤0.01% |
3,848
+3,234
| +527% | +$45.6K |
|
3099
ProShares UltraShort FTSE China 50 of ProShares Trust
FXP
$6.18M
| $53.7K | ﹤0.01% |
+268
| New | +$56.1K |
|
|
AGR
3100
DELISTED
Avangrid, Inc.
AGR
| $53.6K | ﹤0.01% |
1,214
-206
| -15% | -$9.15K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2017 Portfolio in Review
As of Q2 2017, BNP Paribas Financial Markets held 4,445 positions worth $33.2B, down 12% from $37.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BNP Paribas Financial Markets withdrew a net $5.31B in Q2 2017, closing 192 positions and reducing 1,028 holdings. Its most notable exit was Yahoo Inc, an estimated $138M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 11% a quarter earlier, followed by Technology and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in Altaba Inc worth $60.2M.
- BNP Paribas Financial Markets's largest Q2 2017 buy was Altaba Inc: 1,104,690 shares worth $60.2M.
- BNP Paribas Financial Markets added most to Citigroup in Q2 2017, an estimated $799M increase.
- BNP Paribas Financial Markets's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.34B.
- BNP Paribas Financial Markets fully exited Yahoo Inc in Q2 2017, selling an estimated $138M.
- BNP Paribas Financial Markets's ten largest holdings make up 19% of its $33.2B portfolio in Q2 2017.
- BNP Paribas Financial Markets opened 367 new positions and closed 192 in Q2 2017.
- BNP Paribas Financial Markets's portfolio value fell 12% quarter-over-quarter to $33.2B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2017, filed 3 Aug 2017.